Nijmegen, Netherlands

Patrick Gerhard Groothuis

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Patrick Gerhard Groothuis**

Introduction

Patrick Gerhard Groothuis is an accomplished inventor based in Nijmegen, NL. His innovative contributions to the field of biotechnology, particularly in the development of targeted cancer therapies, have led to the creation of two notable patents. Groothuis's work focuses on pioneering approaches that have the potential to transform treatment methodologies for various malignancies.

Latest Patents

Groothuis's latest patents encompass the development of Anti-5T4 antibodies and antibody-drug conjugates (ADCs). The first of these inventions relates to antibodies that target the human 5T4 oncofoetal antigen, with corresponding ADCs that are poised for clinical trials. These antibodies demonstrate cross-reactivity for both humans and cynomolgus monkeys and exhibit a binding affinity for the human 5T4 antigen that is comparable to that for the cynomolgus monkey 5T4 antigen. Moreover, the invention claims the applications of these antibodies and ADCs in treating solid tumors and hematological malignancies. The second patent also concerns CDR defined antibodies targeting the same 5T4 oncofoetal antigen, emphasizing the importance of these discoveries in the ongoing fight against cancer.

Career Highlights

Patrick Groothuis works at Byondis B.V., a company recognized for its commitment to advancing biopharmaceuticals through innovative drug development. His role involves collaborating with a team of skilled professionals dedicated to creating novel therapeutic options. Groothuis's research and patent contributions reflect his commitment to enhancing cancer treatment protocols and improving patient outcomes.

Collaborations

Throughout his career, Groothuis has had the privilege to work alongside talented colleagues, including Miranda Maria Cornelia Van der Lee and Gerardus Joseph Andreas Ariaans. These collaborations underscore the significance of teamwork and shared expertise in driving scientific advancements.

Conclusion

Patrick Gerhard Groothuis exemplifies the spirit of innovation in biotechnology, leveraging his knowledge and skills to contribute to life-saving advancements in cancer treatment. His patents on Anti-5T4 antibodies and antibody-drug conjugates represent a significant step forward in targeted therapy, showcasing how inventors like Groothuis play a vital role in shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…